Replay available

Core Scientific, Inc. (CORZ) Q4 2025 Earnings Call

Core Scientific, Inc. (NASDAQ: CORZ) Q4 2025 earnings conference call, held 2026-03-02. Replay captured from the company's public earnings webcast.

Mon, March 2, 2026 at 4:30 PMendedReplay
Core Scientific, Inc. (CORZ) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

John Charbonneau

Vice President of Investor Relations

Adam Sullivan

Chief Executive Officer

Matt Brown

Chief Operating Officer

Jim Nygaard

Chief Financial Officer

John Peterson

Analyst, Jefferies

Brett Knobloch

Analyst, Cantor Fitzgerald

Henry Hurl

Analyst, B. Riley Securities

George Sutton

Analyst, Craig Callum Capitals Group

Mike Donovan

Analyst, CompassPoint

John Hickman

Analyst, Ladenburg & Company

Kevin Deedy

Analyst, H.C. Wainwright

John Todaro

Analyst, Needham & Company

Ben Somers

Analyst, BTIG

Replay transcript excerpt

Greetings. Welcome to Core Scientific fourth quarter fiscal year 2025 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to John Charbonneau, Vice President of Investor Relations. Thank you. You may begin. Great. Good afternoon and welcome to Core Scientific's fourth quarter and full year 2025 earnings call. Before we begin, I need to remind you that statements made on this call, other than historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on our current expectations. Words such as anticipates, estimates, expects, intends, and believes, and similar words and expressions are intended to identify forward-looking statements. These statements are subject to risks and uncertainties that could cause actual results to differ substantially. For further information on these risks and uncertainties, we encourage you to review the risk factors discussed in the company's reports on Form 10-K 10Q, and 8K filed today with the Securities and Exchange Commission and the press release and slide presentation contained therein. The forward-looking statements we make today speak as of today only, and we do not undertake any obligation to update any such statement to reflect events or circumstances occurring after today. Today's presentation is available on our website, investors.corescientific.com. The content of this conference call contains information that is accurate as of today, March 2nd, 2026. Joini...

More from Core Scientific, Inc.